Pulsenmore

Pulsenmore Asset Growth

The Year-over-Year Total Asset Growth of Pulsenmore (PLSM.TA) as of Oct 27, 2026 is -28.03 %. In the previous year, Year-over-Year Total Asset Growth was -20.67 % — a change of 35.60% (lower).

Asset Growth

-28.03 %

YoY

35.60%

Last updated:

Year-over-Year Total Asset Growth of Pulsenmore is 2025 -28.03 % . Year-over-Year Total Asset Growth of Pulsenmore was 2024 -20.67 % . It decreases by 35.60% lower compared to the previous year.

The Pulsenmore Asset Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Asset Growth
Date
Asset Growth
Jan 1, 2020
42.55 ILS
Jan 1, 2021
1,752.98 ILS
Jan 1, 2022
38.56 ILS
Jan 1, 2023
-22.93 ILS
Jan 1, 2024
-20.67 ILS
Jan 1, 2025
-28.03 ILS
The Pulsenmore Asset Growth history
YEARAsset GrowthYoY
-28.03 %+35.60%
-20.67 %-9.88%
-22.93 %-159.47%
38.56 %-97.80%
1,752.98 %+4,019.53%
42.55 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Pulsenmore Stock analysis

What does Pulsenmore do? Pulsenmore Ltd. generates revenue through the sale of its two miniaturized ultrasound systems, PulseNmore ES and PulseNmore FC, designed for home use in remote clinical diagnosis. The PulseNmore ES targets pregnant women requiring regular ultrasound monitoring, while PulseNmore FC caters to women undergoing in vitro fertilization needing follicle size assessments. Both systems integrate with smartphones, enabling patients to conduct tests at home and share results online with healthcare providers. The company also monetizes through software delivery for its devices, enhancing user experience and data management. The primary buyers of PulseNmore ES are pregnant women seeking convenient, clinic-free monitoring, and healthcare providers managing prenatal care remotely. PulseNmore FC is purchased by women undergoing in vitro fertilization, often through fertility clinics or medical centers that recommend the device. These segments value the convenience of home-based diagnostics and seamless telehealth integration without requiring in-person visits. Pulsenmore Ltd. focuses on global markets for its portable ultrasound solutions, serving patients in remote or underserved areas who benefit from telehealth-enabled diagnostics. The company’s products are positioned as cost-effective alternatives to traditional clinic visits, appealing to both end-users and healthcare institutions aiming to reduce operational costs while maintaining patient care quality. Pulsenmore is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Pulsenmore stock

Year-over-Year Total Asset Growth of Pulsenmore is -28.03 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year Total Asset Growth Pulsenmore since 2006 – with annual values, charts, and detailed analysis.

Asset growth measures the percentage change in total assets. Rapid asset growth may indicate expansion but can also correlate with lower future returns.

To evaluate Year-over-Year Total Asset Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Total Asset Growth.

Year-over-Year Total Asset Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Total Asset Growth's Pulsenmore historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Pulsenmore

All Key Metrics — Pulsenmore